First-line, single-agent Herceptin® (trastuzumab) in metastatic breast cancer: a preliminary report
| Autor: | Vogel, C. *, Cobleigh, M.A., Tripathy, D., Gutheil, J.C., Harris, L.N., Fehrenbacher, L., Slamon, D.J., Murphy, M., Novotny, W.F., Burchmore, M., Shak, S., Stewart, S.J. |
|---|---|
| Zdroj: | In European Journal of Cancer January 2001 37 Supplement 1:25-29 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect